Literature DB >> 15509671

Warfarin reversal.

J P Hanley1.   

Abstract

Warfarin is the most commonly used oral anticoagulant in the UK. It is associated with few side effects apart from haemorrhage. The most appropriate way to reverse the anticoagulant effect of warfarin depends on the clinical circumstances. In serious bleeding, rapid reversal is required, whereas in minor bleeding or asymptomatic over anticoagulation, a more leisurely approach is usually appropriate. This review discusses the current approaches to warfarin reversal in clinical practice. The development of a uniform approach to warfarin reversal in the Northern Region is described.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509671      PMCID: PMC1770479          DOI: 10.1136/jcp.2003.008904

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  71 in total

Review 1.  Managing oral anticoagulant therapy.

Authors:  J Ansell; J Hirsh; J Dalen; H Bussey; D Anderson; L Poller; A Jacobson; D Deykin; D Matchar
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  The use of oral vitamin K for reversal of over-warfarinization.

Authors:  K Pendry; M Bhavnani; K Shwe
Journal:  Br J Haematol       Date:  2001-06       Impact factor: 6.998

3.  Treating thrombosis in the 21st century.

Authors:  Sandor S Shapiro
Journal:  N Engl J Med       Date:  2003-10-30       Impact factor: 91.245

4.  Missense mutations at ALA-10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy.

Authors:  J Oldenburg; E M Quenzel; U Harbrecht; A Fregin; W Kress; C R Müller; H J Hertfelder; R Schwaab; H H Brackmann; P Hanfland
Journal:  Br J Haematol       Date:  1997-07       Impact factor: 6.998

5.  Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk.

Authors:  T G Phan; M Koh; E F Wijdicks
Journal:  Arch Neurol       Date:  2000-12

6.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

Authors:  G Palareti; N Leali; S Coccheri; M Poggi; C Manotti; A D'Angelo; V Pengo; N Erba; M Moia; N Ciavarella; G Devoto; M Berrettini; S Musolesi
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

7.  Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral hemorrhage.

Authors:  J Berwaerts; R S Dijkhuizen; O J Robb; J Webster
Journal:  Stroke       Date:  2000-11       Impact factor: 7.914

8.  Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.

Authors:  R J Patel; D M Witt; J J Saseen; D J Tillman; D S Wilkinson
Journal:  Pharmacotherapy       Date:  2000-10       Impact factor: 4.705

9.  Risk factors for intracranial hemorrhage in outpatients taking warfarin.

Authors:  E M Hylek; D E Singer
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

Review 10.  Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.

Authors:  C S Landefeld; R J Beyth
Journal:  Am J Med       Date:  1993-09       Impact factor: 4.965

View more
  59 in total

1.  Management dilemmas in patients with mechanical heart valves and warfarin-induced major bleeding.

Authors:  Prashanth Panduranga; Mohammed Al-Mukhaini; Muhanna Al-Muslahi; Mohammed A Haque; Abdullah Shehab
Journal:  World J Cardiol       Date:  2012-03-26

Review 2.  Prothrombin complex concentrates: an update.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

3.  [Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage].

Authors:  S Külkens; P Ringleb; J Diedler; W Hacke; T Steiner
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

4.  Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage.

Authors:  Timolaos Rizos; Ekkehart Jenetzky; Christian Herweh; Andreas Unterberg; Werner Hacke; Roland Veltkamp
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

Review 5.  Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation.

Authors:  Hannah A Blair; Gillian M Keating
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

Review 6.  [Intracerebral hemorrhage related to anticoagulant therapy].

Authors:  H B Huttner; E Jüttler; A Hug; M Köhrmann; P D Schellinger; T Steiner
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 7.  [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].

Authors:  Marzia Angelo; Ingrid Stockner; Christian J Wiedermann
Journal:  Wien Med Wochenschr       Date:  2008

8.  Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy.

Authors:  Cezary Wójcik; Michelle L Schymik; Eric G Cure
Journal:  Int J Emerg Med       Date:  2009-11-26

Review 9.  Hereditary combined deficiency of the vitamin K-dependent clotting factors.

Authors:  Mariasanta Napolitano; Guglielmo Mariani; Mario Lapecorella
Journal:  Orphanet J Rare Dis       Date:  2010-07-14       Impact factor: 4.123

10.  Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding.

Authors:  Kerstin S Schick; Jan M Fertmann; Karl-Walter Jauch; Johannes N Hoffmann
Journal:  Crit Care       Date:  2009-11-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.